Several gene targets of NF-kB and STAT3 significantly correlated with UGT2B17 expression consistent with a regulation of UGT2B17 by this signaling axis in leukemic cells of CLL patients. The gene discussed is UGT2B17; the disease is B-cell chronic lymphocytic leukemia.